These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4771857)

  • 1. [Further therapeutic attempts at using molybdenum compounds in rheumatoid atrhritis].
    Krzytmień H
    Pol Tyg Lek; 1973 Nov; 28(46):1808-10. PubMed ID: 4771857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attempts at treating rheumatoid arthritis and other chronic rheumatoid diseases with molybdenum compounds].
    Krzymień H
    Reumatologia; 1970; 8(3):193-8. PubMed ID: 5469424
    [No Abstract]   [Full Text] [Related]  

  • 3. The molybdate urine test in determination of the activity of rheumatoid arthritis.
    Krzymien H
    Pol Med Sci Hist Bull; 1970 Oct; 13(4):154-7. PubMed ID: 5489788
    [No Abstract]   [Full Text] [Related]  

  • 4. [Penicillamine in the therapy of progressive polyarthritis. (2 initial therapeutic attempts with small doses of penicillamine hydrochloride and base)].
    Truhlár P
    Fysiatr Revmatol Vestn; 1972 Jul; 50(3):149-57. PubMed ID: 5064182
    [No Abstract]   [Full Text] [Related]  

  • 5. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
    Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
    Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Penicillamine and rheumatoid polyarthritis (study of 9 cases)].
    Camus JP; Guillien P; Crouzet J; Schaeffer A; Lièvre JA
    Ann Med Interne (Paris); 1970 Feb; 121(2):237-47. PubMed ID: 5491205
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis.
    Richter JA; Runge LA; Pinals RS; Oates RP
    J Rheumatol; 1980; 7(2):153-9. PubMed ID: 7373617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the tolerance to and effectiveness of preparation G-665 and difezil in experimental trichocephaliasis and ganguleterakiasis in white mice].
    Kuznetsova OE; Kolosova MO
    Med Parazitol (Mosk); 1973; 42(6):722-6. PubMed ID: 4783468
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic trials in paediatric rheumatology].
    Guillaume S; Koné-Paut I
    Arch Pediatr; 2008 Jun; 15(5):867-9. PubMed ID: 18582784
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of Doxium tolerance].
    Schwaar R
    Rev Med Suisse Romande; 1971 Feb; 91(2):127-30. PubMed ID: 5579010
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide pulse in combination therapy for refractory rheumatoid arthritis.
    Maeyaert B; Westhovens R; Dequeker J
    J Rheumatol; 1996 Jan; 23(1):197-8. PubMed ID: 8838540
    [No Abstract]   [Full Text] [Related]  

  • 12. The therapeutic action of cyclosporin A (Sandimmun): its application in rheumatoid arthritis.
    Suţeanu ST
    Rom J Intern Med; 1993; 31(2):69-78. PubMed ID: 8268833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the pharmacologic and therapeutic effects of diisopropylammonium dichloroacetate (DIPA).
    Stacpoole PW
    J Clin Pharmacol J New Drugs; 1969; 9(5):282-91. PubMed ID: 4902026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of the hemagglutination reaction with the use of hypertonic solution of ammonium sulfate in the diagnosis of the rheumatoid factor in patients with chronic progressive polyarthritis].
    Stoiia I; Rymiantsu F; Nitsesku S
    Vopr Revm; 1965; 5(2):15-20. PubMed ID: 5851282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Subreum efficacy and tolerance in patients with early rheumatic arthritis].
    Stepanets OV; Chichasova NV; Nasonova MB; Nasonov EL
    Klin Med (Mosk); 2001; 79(11):58-62. PubMed ID: 11811114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digestive tolerance of phenylbutazone with an alkaline coating. Initial therapeutic clinical study of 22 cases. Preliminary report].
    Carneiro RA
    Hospital (Rio J); 1969 Jun; 75(6):2123-30. PubMed ID: 5311469
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation between rheumatoid and antigammaglobulin factors.
    Valeri CM; Pipitone V
    Folia Allergol (Roma); 1970; 17(6):556-69. PubMed ID: 5314141
    [No Abstract]   [Full Text] [Related]  

  • 18. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current therapeutic use of erythromycin. Treatment and tolerance in a group of 132 subjects].
    Guidi G; Corti L; Baroncelli F
    Clin Ter; 1969 Apr; 49(1):35-45. PubMed ID: 5405075
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hygienic regulation of harmful substances in the atmosphere taking into account body adaptational reactions].
    Pazynich VM; Chinchevin VI; Sushko IuD
    Gig Sanit; 1993 Jan; (1):11-4. PubMed ID: 8339956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.